SolasCure Demonstrates Proof-of-Concept in Phase lla Safety Trial of Aurase Wound Gel finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Biotech company SolasCure has announced the results of its proof-of-concept phase 2 trial investigating its wound gel for chronic venous leg ulcer patients.
VirtaMed appoints Andy Weymann, MD, MBA, to Board of Directors VirtaMed, the world leader in medical simulation training, has added Andy Weymann to its board of directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005306/en/
VirtaMed appoints Andy Weymann, MD, MBA, to Board of Directors (Photo: Business Wire)
With more than 25 years of experience working in the medical device and biotech/pharma industry and as an orthopedic surgeon, Andy has extensive experience developing and launching products and a track record leading international medical training initiatives. Prior to joining VirtaMed, Andy spent 13 years as chief medical officer and senior vice president at Smith+Nephew where he provided global leadership and oversight of the Scientific, Clinical and Medical Affairs organization, with accountability for market and business development.